• Latest Posts
Opinion 29 Nov 2023

Redefining drug development: the trailblazing evolution of the pharmaceutical industry

Opinion 1 Nov 2023

Could this be the start of a new era for PI3K drugs?

Opinion 25 Oct 2023

Microbiome: are we ready for third generation live biotherapeutics?

Opinion 27 Sep 2023

Tackling the skilled labor shortage in biopharma manufacturing

Opinion 20 Sep 2023

The next frontier in genomic technologies for rare diseases

Opinion 11 Jul 2023

Unlocking the power of mRNA technology

Opinion 10 Jul 2023

Five innovations to take RNA vaccines to the next level

Opinion 30 Jun 2023

Virus tracking could be key to kidney transplant patients’ drug choices

Opinion 13 Jun 2023

How will European Commission proposals on data exclusivity and the bolar exemption affect pharma companies?

Opinion 9 May 2023

Where is innovation needed in cell therapy?

Opinion 26 Apr 2023

Can mRNA vaccines tackle multiple diseases?